ASH meeting 2014: novità sulle LAL
F. Ferrara e S. Chiaretti
Primi risultati del protocollo GIMEMA LAL 1509
Terapia del MM nell’era dei “nuovi farmaci”
Determinanti genetici di fludarabina-resistenza
Presentazione orale EHA 2013
CMX001 riduce le infezioni da CMV post-SCT
Effetto inibitorio di ruxolitinib sulle DC
Pomalidomide e desametasone nel MM
Molecular profiling per i linfomi T periferici
Studio diagnostico di fase 3
Nuovo IPSS per le mielodisplasie
Immunoterapia genica per la LLC
Blinatumomab in pazienti con LAL
Profilassi della VOD con defibrotide
Alterazioni del gene ATM nella LLC
SF3B1: un nuovo marcatore della LLC a alto rischio
Davide Rossi, M.D., Ph.D
Colite da trapianto di cordone
Review: Regolazione del metabolismo del ferro
Intervista prof.sa Camaschella
Alte dosi di ARA-C inefficaci nella LAM
Mutazioni di DNMT3A nella LAM
Bortezomib monosettimanale: meno tossicità
Epcidina nelle patologie ematologiche
BCR-ABL+ residuo in LMC dopo stop imatinib
Mini-allo per LLC ad alto rischio
Diagnosi istologica di LLC “accelerata”
Microarray utili per la diagnosi delle leucemie
Con un commento del prof. Foà
Nuovi bersagli terapeutici per le LAL dell’adulto
Commento della Dr.sa Chiaretti
LMC: nuovi inibitori crescono
Alta incidenza di VOD con 6-tioguanina
Salute del Sangue Gestione del paziente oncologico complesso UNDER40 in HEMATOLOGY 2016 Final Contest 21° EHA Congress “Basic Immunology” di Piero Musiani e Guido Forni Dalla Plenary dell’ASH: Best Abstracts da Orlando Recita di Natale 2015 Atti 45° Congresso SIE 2015 8° Highlights from EHA disponibile sul sito Ricerca clinica e Leucemia Linfatica Cronica Didattica digitalizzata nella Scuola in Ospedale Scuola in Ospedale – Festa di fine anno Personalizzazione del trattamento e QoL Borsa di studio “Associazione Cristina Bassi” 2015 Recita di Natale 2014 7° Highlights from EHA disponibile sul sito “CML, Myeloproliferative Neoplasms & MM” Festa di fine anno 2013/2014 Manifestazione Rock Your School Hematology Academy for South African Hematologists EHA Learning Center EMATOLOGIA IN PROGRESS Critical insights on CLL and MCL from ASH 2013 5ta edizione del Master in Ematologia Pediatrica Recita di Natale 2013 6° Highlights from EHA disponibile sul sito Love is life 30 anni di allotrapianto presso l'Ematologia Un Centro omnicomprensivo di Ematologia a Roma Festa di fine anno della Scuola in Ospedale MEETING E CONVEGNI l'ARTICOLO DEL MESE INTERVISTE ARCHIVIO NEWS
Tutorial report Banche di cordone I poster presentati all'EHA 2007 H/THJ: nuovo Impact Factor 2007 Obituaries prof. Martino e prof. Mason 236.000 pagine visitate a giugno Ricordo del prof. Martino Jornadas Venezolanas-Italianas de Hematología Hematology Meeting Reports: nuovo numero Meeting ECHO: rituximab nella LLC Lenalidomide, melphalan e prednisone nel MM Ricordo di Fabrizio Aversa Seminario interattivo Mieloma Multiplo 1° premio Piero Martino Alice nel Paese delle Meraviglie 5th Congress of the Lebanese Order of Physicians Chinese delegation in Rome Highlights from EHA Working Party GIMEMA - Linfoproliferative croniche Gli allievi ricordano il prof. Pietro Martino 2° Highlights from EHA sul sito Report: ESH-EHA 12th Tutorial Report: Focus on Hemoglobinopathies and Leukemias Rassegna della letteratura Il nostro Centro vince il bando AIRC 5x1000 Sul sito i protocolli attivi nel nostro Istituto Coordinamento per i trapianti nel Lazio Challenges in CLL today 7th Baltic Conference of Hematology 15° Congresso dell'EHA a Barcellona La Telemedicina per i tumori dei bambini in Iraq Translational Research Training in Hematology 3° Highlights from EHA sul sito Master in Ematologia Pediatrica 2010-2011 Associazione Cristina Bassi onlus Master in Ematologia Pediatrica 2010-2011 Recita di Natale 2010 Ematologia in progress Accessi venosi a medio termine 4° Highlights from EHA disponibile sul sito Borsa di studio “Associazione Cristina Bassi” Prof. Foà: vita di ricercatore Report: New Paradigms in ITP Quasi 1.000.000 di pagine consultate ad ottobre Il Natale 2011 al Reparto Pediatrico EHA: Upcoming events and deadlines Riunione AIRC Progetto 5x1000 Bando UNDER40 in HEMATOLOGY 2015 La mostra dei bambini della Scuola in Ospedale Aggiornamento sul trapianto di cellule staminali “Diagnosi e terapia dei pazienti con linfoma Highlights from EHA 2012 – 5° edizione Primo EHA-CSH Joint Symposium Iscrizione EHA ridotta per i giovani ematologi Brindisi natalizio Nuova unità di Allotrapianto in Ematologia Servizio Prenotazioni Prime Visite non disponibile A tutti i partecipanti della recita di Natale Progetto comune "Sapienza" e Harvard a Baghdad La Scuola in Ospedale si affaccia sulla rete La sala Data Manager dedicata a Daniela De Fazio
Tallinn, 15-17 May 2009
ESH-EHA Tutorial - Focus on Lymphoid Malignancies
On May 15-17, 2009 the 11th ESH - EHA Type II Hematology Tutorial “Diagnostic Work-up of Hematological Malignancies: Focus on Lymphoid Malignancies” was held in Tallinn, the capital of Estonia. 65 participants from 14 countries took part in this high-level education event. The largest number of participants, 21, was from the host country Estonia, followed by the Russian Federation with 13. Although this meeting was initially thought to be “regional”, participants came from all over Europe, as well from Saudi Arabia and even from Canada. One hematologist of the Russian Federation came from Novosibirsk, which is more than three thousand kilometers from Tallinn. Ireland and Portugal were represented both by 6 attendees, France and Slovakia by 3, Czech Republic, Lithuania, Slovenia and United Kingdom by 2 and Latvia, Poland and Spain each by 1. Therefore, the Tutorial was truly international.
Estonia is a small country with 1.3 million inhabitants and it appears that almost every hematologist/hematopathologist working in Estonia took advantage of having the Tutorial at home. Unfortunately, the other Baltic States - Latvia and Lithuania - due to the very severe economic situation were represented both by only 1 hematologist.
The meeting lasted three full days and covered 9 different topics on lymphoid diseases and these topics were covered by 9 international faculty members. The meeting started with a few opening words about Tallinn also in view of the fact that on May 15 Tallinn’s Day is celebrated. On May 15, 1248 the King of Denmark Erik IV gave Tallinn the Lübeck Rights that bound Tallinn to common legal space with medieval German merchant towns.
The scientific program begun with a lecture on the new WHO 2008 classification, by Anna Porwit from Stockholm, Sweden. Anna Porwit is a co-author of many chapters in this classification. The second topic was T- and NK-cell malignancies, a very difficult group of diseases to diagnose and treat discussed by Hans Hagberg from Uppsala, Sweden. The last topic of the first day was presented by Robin Foà from Rome, Italy. He discussed acute lymphoblastic leukemia (ALL), a disease with a poor prognosis for the majority of adult patients. However, the very recent data on tyrosine kinase inhibitors like imatinib and dasatinib on Ph+ ALL were emphasized. The remarkable success and improvement of ALL prognosis with these novel agents were discussed at lenght.
The second day started with Gina Zini, Rome, Italy who gave a lecture on the leukemic phase of B-lineage non-Hodgkin’s lymphoma. She focused on three aggressive high-grade lymphomas – mantle cell lymphoma, diffuse large B-cell lymphoma and Burkitt’s lymphoma. Establishing a correct diagnosis in a short time is critical for these patients, since the treatment program differs between these diseases. The second topic was presented by Estella Matutes from London, UK. She discussed villous lymphocyte lymphomas, hairy cell leukemia (HCL), splenic marginal zone lymphoma with villous lymphocytes and HCL variant. The second day was concluded by chronic lymphocytic leukemia presented by Eva Kimby from Stockholm, Sweden. The newly described entity monoclonal B-cell lymphocytosis created a lively discussion.
The last day of the tutorial started with follicular lymphoma presented by Edward Laane from Tallinn, Estonia. Interestingly this common lymphoma is “quite uncommon” in the Baltic States. Peter Borchmann from Cologne, Germany discussed the treatment experience of the German Hodgkin Lymphoma Study Group, one of the largest and successful investigation groups in Europe for the management of patients with Hodgkin’s lymphoma. The last topic of the Tutorial was multiple myeloma and this was covered by Hele Everaus from Tartu, Estonia.
The standard format of the Tutorial was based on a lecture, 2 tutored clinical cases and self-evaluation cases with voting box systems. Therefore, each topic lasted at least 3 hours and was thoroughly discussed. At the end, the answers to the questions given in the self-evaluation sessions were discussed and commented. The overall evaluation of the meeting by the participants was positive.
The participants and faculty members enjoyed the lovely and open atmosphere of the meeting and the venue. Attendees had the opportunity to experience the beauty and hospitality of Tallinn, especially Old Tallinn, which has been designated as UNESCO World Cultural Heritage site in 1997. Most importantly, we trust that they returned to their homes with an improved knowledge on lymphoid malignancies, which could be used for everyday practice and with many new friends.
We hope to meet again in Estonia in 2011 for a new Tutorial, focused this time on myeloid malignancies.